罕见病的生物标志物。
Biomarkers in Rare Diseases.
机构信息
Institute of Molecular and Clinical Sciences, St. George's University of London, London SW17 0RE, UK.
出版信息
Int J Mol Sci. 2021 Jan 12;22(2):673. doi: 10.3390/ijms22020673.
Abstract
There is no single global definition of a rare disease, and for different geographical areas the definition is based on the disease occurrence in that population [...].
摘要
没有一个全球统一的罕见病定义，不同地区的定义是基于该地区人群中疾病的发生情况而定的[...]。
相似文献
1
Biomarkers in Rare Diseases.罕见病的生物标志物。
Int J Mol Sci. 2021 Jan 12;22(2):673. doi: 10.3390/ijms22020673.
2
Diagnostic challenges and new therapies for rare lysosomal storage diseases.罕见溶酶体贮积病的诊断挑战与新疗法
Case Manager. 2003 Nov-Dec;14(6):48-52. doi: 10.1016/j.casemgr.2003.09.009.
3
Valuable lessons from analyses of common signs and symptoms in rare diseases.罕见病常见体征和症状分析的宝贵经验教训。
Allergol Int. 2021 Oct;70(4):405-406. doi: 10.1016/j.alit.2021.08.011. Epub 2021 Sep 4.
4
Translational genomics for rare cancers: Challenges and opportunity.罕见癌症的转化基因组学：挑战与机遇
Semin Cancer Biol. 2020 Apr;61:iii-iv. doi: 10.1016/j.semcancer.2020.02.014. Epub 2020 Feb 21.
5
[Rare diseases, definitions and epidemiology].[罕见病、定义与流行病学]
Soins Pediatr Pueric. 2013 Sep-Oct(274):14-6.
6
Pharmacological management of rare coagulation factor deficiencies besides hemophilia.除血友病外的罕见凝血因子缺乏症的药物治疗
Expert Rev Hematol. 2020 Aug;13(8):811-834. doi: 10.1080/17474086.2020.1796622. Epub 2020 Oct 6.
7
Spotlight on rare diseases.聚焦罕见病。
Lancet Diabetes Endocrinol. 2019 Feb;7(2):75. doi: 10.1016/S2213-8587(19)30006-3.
8
Rare Lung Disease Research: National Heart, Lung, and Blood Institute's Commitment to Partnership and Progress.罕见肺病研究：美国国立心肺血液研究所对合作与进步的承诺。
Chest. 2019 Sep;156(3):438-444. doi: 10.1016/j.chest.2019.05.004. Epub 2019 May 20.
9
Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.2010 - 2016年罕见病研究进展：国际罕见病研究协作网视角
Clin Transl Sci. 2018 Jan;11(1):11-20. doi: 10.1111/cts.12501. Epub 2017 Oct 23.
10
[Clinical research in rare diseases: new challenges, opportunities and ethical issues].[罕见病的临床研究：新挑战、机遇与伦理问题]
An Pediatr (Engl Ed). 2020 Oct;93(4):219-221. doi: 10.1016/j.anpedi.2020.06.029. Epub 2020 Sep 10.
引用本文的文献
1
Metabolomics: a new frontier in neurodegenerative disease biomarker discovery.代谢组学：神经退行性疾病生物标志物发现的新前沿。
Metabolomics. 2025 May 15;21(3):67. doi: 10.1007/s11306-025-02267-7.
2
The impact of rare diseases on the quality of life in paediatric patients: current status.罕见病对儿科患者生活质量的影响：现状
Front Public Health. 2025 Mar 24;13:1531583. doi: 10.3389/fpubh.2025.1531583. eCollection 2025.
3
Molecular biomarkers, network biomarkers, and dynamic network biomarkers for diagnosis and prediction of rare diseases.用于罕见病诊断和预测的分子生物标志物、网络生物标志物及动态网络生物标志物。
Fundam Res. 2022 Aug 9;2(6):894-902. doi: 10.1016/j.fmre.2022.07.011. eCollection 2022 Nov.
4
Trends in orphan medicinal products approvals in the European Union between 2010-2022.2010-2022 年期间欧盟孤儿药批准的趋势。
Orphanet J Rare Dis. 2024 Feb 27;19(1):91. doi: 10.1186/s13023-024-03095-z.
5
AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa.腺相关病毒介导的碱基编辑疗法改善了视网膜色素变性小鼠模型的疾病表型。
Nat Commun. 2023 Aug 15;14(1):4923. doi: 10.1038/s41467-023-40655-6.
6
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders.为社区主导的全国遗传性出血性疾病研究蓝图奠定基础：超罕见遗传性出血性疾病的研究重点。
Expert Rev Hematol. 2023 Mar;16(sup1):55-70. doi: 10.1080/17474086.2023.2175661.
7
Obtaining the best igRNAs for bystander-less correction of all ABE-reversible pathogenic SNVs using high-throughput screening.利用高通量筛选获得用于旁观者缺失校正所有 ABE 可逆致病性 SNV 的最佳 igRNAs。
Mol Ther. 2023 Apr 5;31(4):1167-1176. doi: 10.1016/j.ymthe.2023.01.028. Epub 2023 Feb 1.
8
Automated high-throughput genome editing platform with an AI learning in situ prediction model.自动化高通量基因组编辑平台，具有人工智能学习原位预测模型。
Nat Commun. 2022 Nov 30;13(1):7386. doi: 10.1038/s41467-022-35056-0.
9
Review of Applications of Near-Infrared Spectroscopy in Two Rare Disorders with Executive and Neurological Dysfunction: UCD and PKU.近红外光谱在两种伴有执行和神经功能障碍的罕见疾病中的应用综述：UCD 和 PKU。
Genes (Basel). 2022 Sep 21;13(10):1690. doi: 10.3390/genes13101690.
10
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.原发性卵磷脂胆固醇脂酰转移酶缺乏症的自然史和生物标志物的系统评价。
J Lipid Res. 2022 Mar;63(3):100169. doi: 10.1016/j.jlr.2022.100169. Epub 2022 Jan 20.
本文引用的文献
1
ChIP-Seq-Based Approach in Mouse Enteric Precursor Cells Reveals New Potential Genes with a Role in Enteric Nervous System Development and Hirschsprung Disease.基于 ChIP-Seq 的方法在小鼠肠前体细胞中的应用揭示了新的潜在基因，这些基因在肠神经系统发育和先天性巨结肠病中具有作用。
Int J Mol Sci. 2020 Nov 28;21(23):9061. doi: 10.3390/ijms21239061.
2
Biomarkers in Rare Demyelinating Disease of the Central Nervous System.中枢神经系统罕见脱髓鞘疾病的生物标志物。
Int J Mol Sci. 2020 Nov 9;21(21):8409. doi: 10.3390/ijms21218409.
3
Implications of Splicing Alterations in the Onset and Phenotypic Variability of a Family with Subclinical Manifestation of Peutz-Jeghers Syndrome: Bioinformatic and Molecular Evidence.具有亚临床表现的 Peutz-Jeghers 综合征家系中剪接改变对发病时间和表型变异性的影响：生物信息学和分子证据。
Int J Mol Sci. 2020 Nov 2;21(21):8201. doi: 10.3390/ijms21218201.
4
Biomarkers in Anderson-Fabry Disease.安德森-法布里病的生物标志物。
Int J Mol Sci. 2020 Oct 29;21(21):8080. doi: 10.3390/ijms21218080.
5
The Emerging and Diverse Roles of Bis(monoacylglycero) Phosphate Lipids in Cellular Physiology and Disease.双（单酰基甘油）磷酸脂质在细胞生理学和疾病中的新兴和多样化作用。
Int J Mol Sci. 2020 Oct 29;21(21):8067. doi: 10.3390/ijms21218067.
6
The Role of and Interplay in Glioma Malignancy and Patient Outcome.在胶质瘤恶性程度和患者预后中的作用及相互关系。
Int J Mol Sci. 2020 Oct 27;21(21):7962. doi: 10.3390/ijms21217962.
7
Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach.基于质谱代谢组学方法鉴定戈谢病 1 型患者可靠的生物标志物谱。
Int J Mol Sci. 2020 Oct 23;21(21):7869. doi: 10.3390/ijms21217869.
8
Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis.成年囊性纤维化患者的血清蛋白质组学分析
Int J Mol Sci. 2020 Oct 8;21(19):7415. doi: 10.3390/ijms21197415.
9
Key Players and Biomarkers of the Adaptive Immune System in the Pathogenesis of Sarcoidosis.适应性免疫系统的关键参与者和生物标志物在结节病发病机制中的作用。
Int J Mol Sci. 2020 Oct 7;21(19):7398. doi: 10.3390/ijms21197398.
10
The Progression of Hemophilic Arthropathy: The Role of Biomarkers.血友病性关节病的进展：生物标志物的作用。
Int J Mol Sci. 2020 Oct 2;21(19):7292. doi: 10.3390/ijms21197292.
Zotero 插件